COVID-19 Patients Clinical Trial
Official title:
A Double-blind, Randomized, Placebo-controlled, Single-ascending Dose Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Following Intramuscular Administration in Healthy Volunteers
This study is designed to assess the safety, tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) in healthy volunteers.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05083104 -
Assessment of the Natural Anticoagulant Profile in Patients With COVID-19
|
||
| Completed |
NCT05162534 -
Independent Predictors on Clinical Outcomes in SARS-CoV2 Patients
|
||
| Completed |
NCT04853979 -
Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure
|
N/A | |
| Completed |
NCT05369676 -
To Evaluate SSD8432/ Ritonavir in Adults With COVID-19
|
Phase 1/Phase 2 | |
| Completed |
NCT05901337 -
Cupping Therapy on Immune System in Post Covid -19
|
N/A | |
| Recruiting |
NCT06349720 -
Investigating Long-term Health Effects and Complications in COVID-19 Recoveries
|
||
| Completed |
NCT04407130 -
Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.
|
Phase 2 | |
| Not yet recruiting |
NCT04427878 -
Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?
|
N/A | |
| Terminated |
NCT04541485 -
To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)
|
Phase 1 | |
| Withdrawn |
NCT04374903 -
Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients
|
N/A |